Bluejay Diagnostics Q4 EPS $(1.78) Misses $(0.68) Estimate

Bluejay Diagnostics, Inc. -10.68%

Bluejay Diagnostics, Inc.




Bluejay Diagnostics (NASDAQ: BJDX) reported quarterly losses of $(1.78) per share which missed the analyst consensus estimate of $(0.68) by 161.76 percent. This is a 25.83 percent increase over losses of $(2.40) per share from the same period last year.
Every question you ask will be answered
Scan the QR code to contact us
Also you can contact us via